# Zoledronate With Atorvastatin in Renal Cell Carcinoma

> **NCT00490698** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 11 (actual)

## Conditions studied

- Kidney Cancer
- Renal Cell Carcinoma

## Interventions

- **DRUG:** Zoledronate
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00490698
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2013-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490698, "Zoledronate With Atorvastatin in Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00490698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*